|
gptkbp:instance_of
|
gptkb:legislation
|
|
gptkbp:affects
|
animal owners
|
|
gptkbp:amended_by
|
gptkb:2022
Animal Drug User Fee Amendments
|
|
gptkbp:applies_to
|
animal drugs
|
|
gptkbp:appointed_by
|
gptkb:FDA
|
|
gptkbp:contributed_to
|
public health
|
|
gptkbp:died_in
|
gptkb:2013
gptkb:2018
|
|
gptkbp:effective_date
|
2003-09-01
|
|
gptkbp:enacted_by
|
gptkb:legislation
|
|
gptkbp:facilitates
|
new drug applications
|
|
gptkbp:goal
|
improve animal health
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Animal Drug User Fee Act
|
|
gptkbp:impact
|
drug approval times
|
|
gptkbp:includes
|
user fee structure
|
|
gptkbp:influences
|
drug pricing
|
|
gptkbp:introduced
|
gptkb:legislation
|
|
gptkbp:is_criticized_for
|
potential conflicts of interest
|
|
gptkbp:is_discussed_in
|
legislative hearings
|
|
gptkbp:is_evaluated_by
|
gptkb:GAO
|
|
gptkbp:is_implemented_in
|
FDA Center for Veterinary Medicine
|
|
gptkbp:is_linked_to
|
animal welfare
|
|
gptkbp:is_monitored_by
|
gptkb:Office_of_Management_and_Budget
|
|
gptkbp:is_part_of
|
Animal Drug User Fee Amendments of 2008
Animal Drug User Fee Amendments of 2013
Animal Drug User Fee Amendments of 2018
Animal Drug User Fee Amendments of 2022
Animal Health Legislation
|
|
gptkbp:is_promoted_by
|
animal health advocates
|
|
gptkbp:is_related_to
|
gptkb:Food_and_Drug_Administration_Modernization_Act
|
|
gptkbp:is_reviewed_by
|
Congressional committees
|
|
gptkbp:is_subject_to
|
federal regulations
|
|
gptkbp:is_supported_by
|
pharmaceutical companies
veterinary associations
|
|
gptkbp:is_used_to
|
fund drug reviews
|
|
gptkbp:is_valued_for
|
streamlining processes
|
|
gptkbp:promotes
|
innovation in veterinary medicine
|
|
gptkbp:provides
|
financial resources for FDA
|
|
gptkbp:purpose
|
to expedite the approval of animal drugs
|
|
gptkbp:receives_funding_from
|
user fee program
|
|
gptkbp:regulates
|
animal drug approvals
|
|
gptkbp:related_to
|
Veterinary Medicine
|
|
gptkbp:requires
|
annual reports
|
|
gptkbp:revenue
|
user fees
|
|
gptkbp:set_in
|
user fee rates
|
|
gptkbp:signed_by
|
gptkb:President_George_W._Bush
|
|
gptkbp:supports
|
research and development
|
|
gptkbp:trigger_type
|
increased scrutiny of drug applications
|
|
gptkbp:bfsParent
|
gptkb:U._S._Food_and_Drug_Administration
|
|
gptkbp:bfsLayer
|
4
|